{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:20:59Z","timestamp":1780320059231,"version":"3.54.1"},"reference-count":50,"publisher":"Portland Press Ltd.","issue":"4","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In the light of hepatocyte growth factor (HGF) the inhibiting role on the expression of hepcidin, we hypothesized that HGF might be able to reduce cell and tissue iron by increasing ferroportin 1 (Fpn1) content and Fpn1-mediated iron release from cells and tissues. The hypothesized ability of HGF to reduce iron might be one of the mechanisms associated with its neuroprotective action under the conditions of ischemia\/reperfusion (I\/R). Here, we investigated the effects of HGF on the expression of hepcidin as well as transferrin receptor 1 (TfR1), divalent metal transporter 1 (DMT1), Fpn1, ferritin and iron regulatory proteins (IRPs) in oxygen-glucose deprivation and reoxygenation (OGD\/R)-treated PC12 cells by real-time PCR and Western blot analysis. We demonstrated that HGF could completely reverse the OGD\/R-induced reduction in Fpn1 and IRP1 expression and increase in ferritin light chain protein and hepcidin mRNA levels in PC12 cells. It was concluded that HGF protects PC12 cells against OGD\/R-induced injury mainly by reducing cell iron contents via the up-regulation of Fpn1 and increased Fpn1-mediated iron export from cells. Our findings suggested that HGF may also be able to ameliorate OGD\/R or I\/R-induced overloading of brain iron by promoting Fpn1 expression.<\/jats:p>","DOI":"10.1042\/bsr20200287","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T13:54:20Z","timestamp":1584539660000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatocyte growth factor protects PC12 cells against OGD\/R-induced injury by reducing iron"],"prefix":"10.1042","volume":"40","author":[{"given":"Siyue","family":"Li","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-938X","authenticated-orcid":false,"given":"Zhong-Ming","family":"Qian","sequence":"additional","affiliation":[{"name":"Institute of Translational and Precision Medicine, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaojing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Institute of Translational and Precision Medicine, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"2021111620060846600_B1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0006-291X(89)92316-4","article-title":"Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor","volume":"163","author":"Miyazawa","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021111620060846600_B2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/342440a0","article-title":"Molecular cloning and expression of human hepatocyte growth factor","volume":"342","author":"Nakamura","year":"1989","journal-title":"Nature"},{"key":"2021111620060846600_B3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1440-1746.2010.06549.x","article-title":"Hepatocyte growth factor twenty years on: Much more than a growth factor","volume":"26","author":"Nakamura","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2021111620060846600_B4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cyto.2016.12.025","article-title":"Hepatocyte growth factor in physiology and infectious diseases","volume":"98","author":"Imamura","year":"2017","journal-title":"Cytokine"},{"key":"2021111620060846600_B5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/biomedicines2040247","article-title":"HGF\/Met Axis in Heart Function and Cardioprotection","volume":"2","author":"Gallo","year":"2014","journal-title":"Biomedicines"},{"key":"2021111620060846600_B6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/hum.2017.217","article-title":"Hepatocyte Growth Factor Gene Therapy for Ischemic Diseases","volume":"29","author":"Wang","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"2021111620060846600_B7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/6310","article-title":"Hepatocyte growth factor, a versatile signal for developing neurons","volume":"2","author":"Maina","year":"1999","journal-title":"Nat. Neurosci."},{"key":"2021111620060846600_B8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1006\/cyto.2001.0875","article-title":"Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions","volume":"14","author":"Kern","year":"2001","journal-title":"Cytokine"},{"key":"2021111620060846600_B9","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bbrc.2004.05.100","article-title":"Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction","volume":"319","author":"Date","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021111620060846600_B10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/sj.jcbfm.9600273","article-title":"Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector","volume":"26","author":"Zhao","year":"2006","journal-title":"J. Cereb. Blood. Flow Metab."},{"key":"2021111620060846600_B11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/jcbfm.2010.211","article-title":"Acute hepatocyte growth factor treatment induces long-term neuroprotection and stroke recovery via mechanisms involving neural precursor cell proliferation and differentiation","volume":"31","author":"Doeppner","year":"2011","journal-title":"J. Cereb. Blood. Flow Metab."},{"key":"2021111620060846600_B12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00004647-199804000-00001","article-title":"Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor","volume":"18","author":"Miyazawa","year":"1998","journal-title":"J. Cereb. Blood. Flow Metab."},{"key":"2021111620060846600_B13","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/sj.jcbfm.9600287","article-title":"Prevention of apoptosis-inducing factor translocation is a possible mechanism for protective effects of hepatocyte growth factor against neuronal cell death in the hippocampus after transient forebrain ischemia","volume":"26","author":"Niimura","year":"2006","journal-title":"J. Cereb. Blood. Flow Metab."},{"key":"2021111620060846600_B14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jnr.22524","article-title":"Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion","volume":"89","author":"Shang","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"2021111620060846600_B15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0165-0173(98)00012-5","article-title":"Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders","volume":"27","author":"Qian","year":"1998","journal-title":"Brain Res. Rev."},{"key":"2021111620060846600_B16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(03)00353-3","article-title":"Iron misregulation in the brain: a primary cause of neurodegenerative disorders","volume":"2","author":"Ke","year":"2003","journal-title":"Lancet Neurol."},{"key":"2021111620060846600_B17","article-title":"Hepcidin and its therapeutic potential in neurodegenerative disorders","author":"Qian","year":"2019","journal-title":"Med. Res. Rev."},{"key":"2021111620060846600_B18","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/01.STR.25.8.1543","article-title":"Iron-related damage in acute ischemic stroke","volume":"25","author":"D\u00e1valos","year":"1994","journal-title":"Stroke"},{"key":"2021111620060846600_B19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1161\/01.STR.29.2.487","article-title":"Low molecular weight iron in cerebral ischemic acidosis in vivo","volume":"29","author":"Lipscomb","year":"1998","journal-title":"Stroke"},{"key":"2021111620060846600_B20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2174\/092986707780363014","article-title":"Iron, oxidative stress and early neurological deterioration in ischemic stroke","volume":"14","author":"Carbonell","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"2021111620060846600_B21","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.jocn.2009.01.020","article-title":"Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia","volume":"16","author":"Li","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"2021111620060846600_B22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/ijs.12391","article-title":"Protective effect of grape seed and skin extract on cerebral ischemia in rat: implication of transition metals","volume":"10","author":"Safwen","year":"2015","journal-title":"Int. J. Stroke"},{"key":"2021111620060846600_B23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.25615","article-title":"Inhibition of hepcidin transcription by growth factors","volume":"56","author":"Goodnough","year":"2012","journal-title":"Hepatology"},{"key":"2021111620060846600_B24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1042\/BJ20121518","article-title":"Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2","volume":"450","author":"Maurer","year":"2013","journal-title":"Biochem. J."},{"key":"2021111620060846600_B25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and disorders of iron metabolism","volume":"62","author":"Ganz","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"2021111620060846600_B26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.neuint.2005.06.004","article-title":"Iron loading inhibits ferroportin1 expression in PC12 cells","volume":"47","author":"Chen","year":"2005","journal-title":"Neurochem. Int."},{"key":"2021111620060846600_B27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.neuint.2005.02.008","article-title":"Treatment with nerve growth factor decreases expression of divalent metal transporter 1 and transferrin receptor in PC12 cells","volume":"47","author":"Wang","year":"2005","journal-title":"Neurochem. Int."},{"key":"2021111620060846600_B28","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/jcbfm.2015.97","article-title":"CX3CL1\/CX3CR1-mediated microglia activation plays a detrimental role in ischemic mice brain via p38MAPK\/PKC pathway","volume":"35","author":"Liu","year":"2015","journal-title":"J. Cereb. Blood. Flow Metab."},{"key":"2021111620060846600_B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2016.10.029","article-title":"(Z)-ligustilide increases ferroportin1 expression and ferritin content in ischemic SH-SY5Y cells","volume":"792","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"2021111620060846600_B30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11064-010-0327-8","article-title":"A synergistic role of hyperthermic and pharmacological preconditioning to protect astrocytes against ischemia\/reperfusion injury","volume":"36","author":"Du","year":"2011","journal-title":"Neurochem. Res."},{"key":"2021111620060846600_B31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.biocel.2007.10.013","article-title":"Ginkgolides mimic the effects of hypoxic preconditioning to protect C6 cells against ischemic injury by up-regulation of hypoxia-inducible factor-1 alpha and erythropoietin","volume":"40","author":"He","year":"2008","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"2021111620060846600_B32","doi-asserted-by":"publisher","first-page":"e4593","DOI":"10.1371\/journal.pone.0004593","article-title":"L-DOPA neurotoxicity is mediated by up-regulation of DMT1-IRE expression","volume":"4","author":"Du","year":"2009","journal-title":"PLoS ONE"},{"key":"2021111620060846600_B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2017.10.001","article-title":"Aspirin increases ferroportin 1 expression by inhibiting hepcidin via the JAK\/STAT3 pathway in interleukin 6-treated PC-12 cells","volume":"662","author":"Huang","year":"2018","journal-title":"Neurosci. Lett."},{"key":"2021111620060846600_B34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.neurobiolaging.2013.11.004","article-title":"Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease","volume":"35","author":"Huang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"2021111620060846600_B35","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.jnutbio.2011.12.002","article-title":"The iron regulatory hormone hepcidin inhibits expression of iron release as well as iron uptake proteins in J774 cells","volume":"23","author":"Du","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"2021111620060846600_B36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jcb.20303","article-title":"La3+-promoted proliferation is interconnected with apoptosis in NIH 3T3 cells","volume":"94","author":"Yu","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"2021111620060846600_B37","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1124\/mol.105.017756","article-title":"Increased divalent metal transporter 1 expression might be associated with the neurotoxicity of L-DOPA","volume":"69","author":"Chang","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"2021111620060846600_B38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cmet.2007.10.006","article-title":"Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum","volume":"7","author":"Galy","year":"2008","journal-title":"Cell Metab."},{"key":"2021111620060846600_B39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"2021111620060846600_B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6107(97)00009-6","article-title":"Iron crosses the endosomal membrane by a carrier-mediated process","volume":"67","author":"Qian","year":"1997","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"2021111620060846600_B41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-5793(89)81040-3","article-title":"Identification of the ferroxidasecentre in ferritin","volume":"254","author":"Lawson","year":"1989","journal-title":"FEBS Lett."},{"key":"2021111620060846600_B42","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti","year":"2002","journal-title":"Blood"},{"key":"2021111620060846600_B43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"key":"2021111620060846600_B44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.nutr.26.061505.111303","article-title":"Regulation of iron metabolism by hepcidin","volume":"26","author":"Nemeth","year":"2006","journal-title":"Annu. Rev. Nutr."},{"key":"2021111620060846600_B45","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1210\/en.2007-1626","article-title":"Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantianigra in rat brain","volume":"149","author":"Wang","year":"2008","journal-title":"Endocrinology"},{"key":"2021111620060846600_B46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12035-014-8847-x","article-title":"Hepcidin suppresses brain iron accumulation by downregulating iron transport proteins in iron-overloaded rats","volume":"52","author":"Du","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"2021111620060846600_B47","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"2021111620060846600_B48","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat. Med."},{"key":"2021111620060846600_B49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.nutr.28.061807.155521","article-title":"Systemic iron homeostasis and the iron-responsive element\/iron-regulatory protein (IRE\/IRP) regulatory network","volume":"28","author":"Muckenthaler","year":"2008","journal-title":"Annu. Rev. Nutr."},{"key":"2021111620060846600_B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1306.001","article-title":"Iron metabolism and the IRE\/IRP regulatory system: an update","volume":"1012","author":"Pantopoulos","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20200287\/870662\/bsr-2020-0287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20200287\/870662\/bsr-2020-0287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:43:25Z","timestamp":1637095405000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/40\/4\/BSR20200287\/222408\/Hepatocyte-growth-factor-protects-PC12-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20200287","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,3,31]]},"article-number":"BSR20200287"}}